KARS1 and schizophrenia: In addition, understanding these interactions at the molecular level possibly would allow to improve the therapeutic possibilities to treat putative KAR-related diseases, such as ischemia, persistent pain perception, and schizophrenia (see [12] for a review on KARs and their putative connection to certain diseases).